Jan Smeitink is the founder and CEO of Khondrion. He is also a renowned expert in the field of mitochondrial medicine, and currently holds a position as Professor Emeritus in Mitochondrial medicine at Radboud University. He is the founding director of the Radboud Center for Mitochondrial Medicine. With over 25 years of dedicated research and patient care, he has made significant contributions to the understanding and treatment of mitochondrial diseases.

Smeitink's groundbreaking research has led to numerous peer-reviewed publications and the supervision of countless PhD students, many of whom have gone on to become leading experts in the field. His dedication to patient care and scientific discovery has been recognized with the prestigious Knight in the Order of the Dutch Lion. His passion and expertise are driving Khondrion's mission to develop innovative therapies for mitochondrial diseases.